Our next webinar will take place on Wednesday 12th June 2019. Panelists will discuss recent publications in the field of dopamine replacement cell therapy for Parkinson’s. It is topical and timely following the recent G-Force-PD meeting that was hosted by Professor Roger Barker in Cambridge, which brought together researchers leading the dopamine replacement cell therapy clinical trials.
Our latest webinar took place on Wednesday 6th March 2019. Professor Patrick Brundin chaired the panel discussion on Sleep in Parkinson’s, featuring recent papers including: ‘The sleep-wake cycle regulates brain insterstitial fluid tau in mice and CSF tau in humans’.
Our third webinar took place on Wednesday 5th December 2018. Chair Professor Patrick Brundin was joined by Dr Ziv Gan-Or, Benjamin Stetcher, Dr Roy Alcalay, Dr Gaurav Gupta and Jonathan Silverstein to discuss recent papers from Genetics to the Clinic.
Professor Brundin was joined by fellow panellists Professor Tom Foltynie from University College London (UCL), who led the exenatide trial, Nigel Greig and Dimitrios Kapogiannis from the National Institute of Ageing (NIA), and exenatide trial participant Penny Kustow.
The inaugural webinar discussion led by Chair Professor Patrick Brundin examined the paper “What effects might exenatide have on non-motor symptoms in Parkinson’s disease: A post hoc analysis”, by Dr Dilan Athauda et al (read our PM summary here).